A regional cooperative clinical study of radiotherapy for cervical cancer in east and south-east Asian countries

Radiotherapy and Oncology

Volumn 84, Issue 3, 2007, Pages 314-319

  Nakano, Takashi ^a   Kato, Shingo ^b   Cao, Jianping ^c   Zhou, Juying ^c   Susworo, Raden ^d   Supriana, Nana ^d   Sato, Shinichiro ^b   Ohno, Tatsuya ^b   Suto, Hisao ^e   Nakamura, Yuzuru ^f   Cho, Chul Koo ^g   Ismail, Fuad B ^h   Calaguas, Miriam J C ⁱ   de los Reyes, Rey H ^j   Chansilpa, Yaowalak ^k   Thephamongkhol, Kullathom ^k   Duc, Nguyen Ba ^l   Dung, To Anh ^l   Tsujii, Hirohiko ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c SOOCHOW UNIVERSITY   (China)

^d CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^e Matsudo City Hospital   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g Korea Cancer Center Hospital   (South Korea)

^h UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

ⁱ ST LUKE S MEDICAL CENTER   (Philippines)

^j Jose R Reyes Memorial Medical Center   (Philippines)

^k MAHIDOL UNIVERSITY   (Thailand)

^l National Cancer Institute   (Viet Nam)

more..

Author keywords

Cervical cancer; Developing country; East and south east Asia; International clinical study; Radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER STAGING; CULTURAL FACTOR; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SOCIOECONOMICS; SOUTHEAST ASIA; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ASIA, SOUTHEASTERN; BRACHYTHERAPY; FAR EAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 34548427030     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.05.012     Document Type: Article

References (20)

1. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiotherapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
2. Craighead P.S., Smulian H.G., de Groot H.J., and du Toit P.F.M. Are recommendations from carcinoma of the cervix patterns of care studies (PCS) in the United States of America (USA) applicable to centers in developing countries?. Int J Radiat Oncol Biol Phys 37 (1997) 803-810
3. Dobrowsky W., Huigol N.G., Jayatilake R.S., et al. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicenter randomized trial. Radiother Oncol 82 (2007) 24-29
4. Eifel P.J., Levenback C., Wharton T., and Oswald M.J. Time course and incidence of late complications in patients treated with radiotherapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32 (1995) 1289-1300
5. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiotherapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
6. Eifel PJ. The uterine cervix. In: Cox JD, Ang KK, editor. Radiation oncology: Rationale, technique, results. Mosby, St. Louis; 2003. p. 681-723, chapter 28.
7. Forum for Nuclear Cooperation in Asia. Available from: .
8. Horiot J.C., Pigneux J., Pourquier H., et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 14 (1988) 605-611
9. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 42 (1998) 531-540
10. Nakano T., Kato S., Ohno T., et al. Long-term results of high-dose-rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103 (2005) 92-101
11. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
12. Patel F.D., Shama S.C., Negi P.S., Ghoshal S., and Gupta B.D. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 28 (1994) 335-341
13. Perez C.A., Grigsby P.W., Castro-Vita H., and Lockett M.A. Carcinoma of the uterine cervix. 1. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiotherapy. Int J Radiat Oncol Biol Phys 32 (1995) 1275-1288
14. Perez C.A., Grigsby P.W., Chao C., Mutch D.G., and Lockett M.A. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-317
15. Quinn M.A., Benedet J.L., Odicino F., et al. Carcinoma of the cervix uteri. In the 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 95 (2006) 43-103
16. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
17. Tatsuzaki H., and Levin C.V. Quantitative status of resources for radiotherapy in Asia and Pacific region. Radiother Oncol 60 (2001) 81-89
18. Teshima T., Inoue T., Ikeda H., et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka university hospital. Cancer 72 (1993) 2409-2414
19. Thomas G. Cervical cancer: treatment challenges in the developing world. Radiother Oncol 79 (2006) 139-141
20. Whitney C.W., Sause W., Bundy B.N., et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjuvant to radiotherapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348